Cargando…
A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is the reason for this ongoing pandemic infection diseases termed coronavirus disease 2019 (COVID-19) that has emerged since early December 2019 in Wuhan City, Hubei Province, China. In this century, it is the worst threat to international...
Autores principales: | Rameshrad, Maryam, Ghafoori, Majid, Mohammadpour, Amir Hooshang, Nayeri, Mohammad Javad Dehghan, Hosseinzadeh, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235439/ https://www.ncbi.nlm.nih.gov/pubmed/32430617 http://dx.doi.org/10.1007/s00210-020-01901-6 |
Ejemplares similares
-
Evaluation of berberine pellet effect on clinical recovery time in COVID-19 outpatients: A pilot clinical trial
por: Omidvar Tehrani, Soodabeh, et al.
Publicado: (2023) -
An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome: A drug repositioning
por: Rameshrad, Maryam, et al.
Publicado: (2020) -
Protective effects and therapeutic applications of ellagic acid against natural and synthetic toxicants: A review article
por: Naraki, Karim, et al.
Publicado: (2022) -
Evaluating the Effects and Safety of Intravenous Lipid Emulsion on Haloperidol-Induced Neurotoxicity in Rabbit
por: Moshiri, Mohammad, et al.
Publicado: (2014) -
Evaluation of possible effects of crocin against nitrate tolerance and endothelial dysfunction
por: Omidkhoda, Seyedeh Farzaneh, et al.
Publicado: (2020)